Ordspono

odronextamab · Regeneron Ireland Designated Activity Company (DAC)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ordspono, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: EMA Authorised: Ordspono (odronextamab) — Regeneron Ireland Designated Activity Company (DAC)